Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 605

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 605
---
 that the Company register such securities. In addition, these holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of the Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Chardan may not exercise its demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the registration statement of which this prospectus forms a part and may not exercise its demand rights on more than one occasion. F-42 BELLEVUE LIFE SCIENCES ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 NOTE 5 — COMMITMENTSANDCONTINGENCIES (cont.) Underwriting Agreement The Company granted the underwriters a 45 -dayoption from the final prospectus relating to the Initial Public Offering to purchase up to 900,000additional Units to cover over -allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters were entitled to an underwriting discount of $ 0.20per Unit, or $ 1,200,000in the aggregate, equal to 2% of the gross proceeds of the Initial Public Offering (or $ 1,380,000in the aggregate if the underwriters’ over -allotmentoption is exercised in full), payable upon the closing of the Initial Public Offering; provided that for each Unit purchased by investors that are sourced by the Sponsor, such underwriting discount was reduced to $ 0.125per Unit payable in cash. In addition, $ 0.30per Unit, or approximately $ 1,800,000in the aggregate (or $ 2,070,000in the aggregate if the underwriters’ over -allotmentoption is exercised in full) will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amount held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In addition, the underwriters are entitled to receive 30,000shares of Common Stock (or 34,500shares if the underwriters’ over -allotmentoption is exercised in full) from the Sponsor, which will be placed in escrow until the consumm